MicroPort CardioFlow Medtech Corporation (HKG:2160)
3.150
-0.030 (-0.95%)
Apr 20, 2026, 4:08 PM HKT
HKG:2160 Revenue
In the year 2025, MicroPort CardioFlow Medtech had annual revenue of $57.04M USD with 15.16% growth. MicroPort CardioFlow Medtech had revenue of $24.29M in the half year ending December 31, 2025, with 7.80% growth.
Revenue
$57.04M
Revenue Growth
+15.16%
P/S Ratio
9.03
Revenue / Employee
$136.80K
Employees
417
Market Cap
4.01B HKD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 57.04M | 7.51M | 15.16% |
| Dec 31, 2024 | 49.54M | 2.12M | 4.47% |
| Dec 31, 2023 | 47.41M | 11.02M | 30.28% |
| Dec 31, 2022 | 36.40M | 4.78M | 15.13% |
| Dec 31, 2021 | 31.61M | 15.69M | 98.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Isotope & Radiation | 8.00B |
| AK Medical Holdings | 1.65B |
| Zylox-Tonbridge Medical Technology | 1.18B |
| Beijing Chunlizhengda Medical Instruments | 1.16B |
| MicroPort NeuroScientific | 879.66M |
| Peijia Medical | 793.29M |
| MicroTech Medical (Hangzhou) | 735.33M |
| Acotec Scientific Holdings | 717.35M |